Maternal hyperphenylalaninaemia as a cause of microcephaly and mental retardation

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 8, 1996, Pages 943-946

  Jardim, L B ^a,b   Palma Dias, R ^b   Silva, Lcs ^b   Ashton Prolla, P ^b   Giugliani, R ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Maternal hyperphenylalaninaemia; Maternal phenylketonuria; Mental retardation; Microcephaly

Indexed keywords

PHENYLALANINE;

ADULT; ARTICLE; BLOOD LEVEL; FAMILIAL DISEASE; HUMAN; HYPERPHENYLALANINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MATERNAL DISEASE; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN; PHENYLKETONURIA; PRIORITY JOURNAL; SCREENING;

EID: 0029744755     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14191.x     Document Type: Article

References (16)

1. Scriver RL, Kaufmann S, Woo SLC. The hyperphenylalaninemias. In: Scriver RL, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989
2. Guttler F, Lou H. Phenylketonuria and hyperphenylalaninemia. in: Fernandes J, Saudubray JM, Tada K, editors. Inborn metabolic diseases. Berlin: Springer-Verlag, 1990
3. Smith I. Disorders of tetrahydrobiopterin metabolism. In: Fernandes J, Saudubray JM, Tada K, editors. Inborn metabolic diseases. Berlin: Springer-Verlag, 1990
4. Jardim LB, Silveira EL, Leite JCL, Barth ML, Giugliani R. [A preliminary report from an aminoacid screening program for newborns in Rio Grande do Sul, Brazil] (Port.; abstract in English). Jornal de Pediatria 1992;68:189-91
5. Lenke RR, Levy HL. Maternal PKU and HPA: an international survey of untreated and treated pregnancies. N Engl J Med 1980;303:1202
6. McCaman MW, Robins E. Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 1962;59:885-90
7. Caballero, et al. Plasma amino acid levels after single-dose aspartame-consumption in phenylketonuria, mild hyperphenylalaninemia and heterozygous state for phenylketonuria. J Pediatr 1986;109:668-71
8. Debt CE. Relation of biochemical abnormality in development of mental defect in phenylketonuria. Etiological factors in MR. 23rd Ross Pediatric Research Conf, November, Columbus, OH, 1956: p. 32
9. Mabry CC, Denniston JC, Nelson TL, Son CD. Maternal phenylketonuria: a cause of M R in children without metabolic defect. N Engl J Med 1963;269:1404-8
10. Appleton RE, Bruner JH, Holton JB. A loophole in the PKU screening programme. Lancet 1984;2:752
11. Levy HL, Lobbregt D, Waisbren SE, Koch R, Hanley WB, Matalon R, et al.. Maternal mild hyperphenylalaninemia. Abstract: VI Int Cong of Inborn Errors of Metabolism, Milano, Italy, 1994
12. Koch R, Levy H, Matalon R, Rouse B, Hanley W, Azen C. The north american collaborative study of maternal phenylketonuria status report 1993. Am J Dis Child 1993;147:1224-30
13. Platt LD, Koch R, Azen C, Hanley W, Levy H, Matalon R, et al. Maternal phenyketonuria collaborative study,obstetric aspects and outcome: the first six years. Am J Obstet Gynecol 1992;166: 1150-62
14. Levy HL, Waisbren SE, Lobbregt D, Allred E, Schuler A, Trefz FK, et al. Maternal mild hyperphenylalaninaemia: an international survey of offspring outcome. Lancet 1994;344: 1589-94
15. Merkatz IR, Duchon MA, Yamashita TS, Houser HB. A pilot community-based screening program for gestational diabetes. Diabetes Care 1980;3:453-457
16. Hanley WB. Prenatal testing for maternal phenylketonuria (MPKU). Int Pediatr 1994; 9 Suppl 2:33-39